Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 61 (Search time: 0.002 seconds).
previous
1
2
3
4
...
7
next
Item hits:
Preview
Issue Date
Title
Author(s)
2014
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint
Branford, S.
;
Ross, D.
;
Yeung, D.
;
Braley, J.
;
Hughes, T.
;
56th ASH Annual Meeting (6 Dec 2014 - 9 Dec 2014 : San Francisco, California)
2010
Selective escalation of imatinib therapy and early switching to nilotinib in de novo chronic phase CML patients: interim results from the TIDELL-II trial
Yeung, D.
;
Osborn, M.
;
White, D.
;
Branford, S.
;
Haswell, L.
;
Slader, C.
;
Issa, S.
;
Hiwase, D.
;
Hertzberg, M.
;
Schwarer, A.
;
Filshie, R.
;
Arthur, C.
;
Kwan, Y.
;
Forsyth, C.
;
Ross, D.
;
Mills, A.
;
Grigg, A.
;
Hughes, T.
;
Annual Meeting of the American Society of Hematology (52nd : 2010 : Orlando, Fl.)
2010
Mutation analysis of BCR-ABL tyrosine kinase domain in new chronic phase-chronic myeloid leukemia patients with suboptimal response or treatment failure from imatinib treatment
Kim, D.
;
Kim, D.
;
Kim, S.
;
Goh, H.
;
Pane, F.
;
Hughes, T.
;
Radich, J.
;
Lin, P.
;
Saglio, G.
;
Branford, S.
;
Martinelli, G.
;
Soverini, S.
;
Hochhaus, A.
;
American Society of Hematology Meeting (52nd : 2010 : Florida, CA.)
2003
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase
Branford, S.
;
Rudzki, Z.
;
Harper, A.
;
Grigg, A.
;
Taylor, K.
;
Durrant, S.
;
Arthur, C.
;
Browett, P.
;
Schwarer, A.
;
Ma, D.
;
Seymour, J.
;
Bradstock, K.
;
Joske, D.
;
Lynch, K.
;
Gathmann, I.
;
Hughes, T.
2010
A Review of Mutation Analysis In the TOPS Trial of Standard Dose Versus High Dose IM In CML Suggests That Refinements to the ELN Recommendations for Mutation Screening May Be Appropriate
Branford, S.
;
Goh, H.
;
Izzo, B.
;
Beppu, L.
;
Ortmann, C.
;
Duniec, K.
;
Jin, Y.
;
Woodman, R.
;
Pane, F.
;
Kim, D.
;
Radich, J.
;
Hughes, T.
;
American Society of Hematology Meeting (52nd : 2010 : Florida, CA.)
2010
Detection of low level nilotinib or dasatinib resistant BCR-ABL mutations by mass spectrometry in CML patients who fail Imatinib is highly predivtive of their subsequent clonal expansion when treated with the drug for which their mutation confers resistance
Parker, W.
;
Ho, M.
;
Lawrence, R.
;
Irwin, D.
;
Scott, H.
;
Hughes, T.
;
Branford, S.
;
American Society of Hematology Meeting (52nd : 2010 : Florida, CA.)
2002
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance
Branford, S.
;
Rudzki, Z.
;
Walsh, S.
;
Grigg, A.
;
Arthur, C.
;
Taylor, K.
;
Herrmann, R.
;
Lynch, K.
;
Hughes, T.
2010
Towards DNA-based monitoring of therapy in chronic myeloid leukemia
Morley, A.
;
Bartley, P.
;
Ross, D.
;
Latham, S.
;
Budgen, B.
;
Branford, S.
;
Hughes, T.
;
American Society of Hematology Meeting (52nd : 2010 : Florida, CA.)
2010
Contrasting response of patients with chronic myeloid leukaemia (CML) and the highly imatinib resistant L248V mutation that may be related to an increased propensity of some patients to form an associated deletion mutant with increased imatinib sensitivity
Prime, H.
;
Romeo, G.
;
Phillis, S.
;
Field, C.
;
Jamison, B.
;
Prime, J.
;
Parker, W.
;
Joske, D.
;
Hughes, T.
;
Branford, S.
;
Haematology Association of Australasia Annual Meeting (2010 : Auckland, New Zealand)
2007
Monitoring disease response
Hughes, T.
;
Branford, S.
;
Melo, J.
;
Goldman, J.
Discover
Author
15
Radich, J.
15
Ross, D.
13
Yeung, D.
11
Hochhaus, A.
10
Grigg, A.
10
Seymour, J.
8
Arthur, C.
8
Kim, D.
8
Parker, W.
8
Rudzki, Z.
.
next >
Subject
24
Humans
23
Leukemia, Myelogenous, Chronic, B...
21
Fusion Proteins, bcr-abl
21
Pyrimidines
20
Benzamides
20
Piperazines
17
Imatinib Mesylate
13
Antineoplastic Agents
11
Male
11
Middle Aged
.
next >
Date issued
1
2020 - 2022
35
2010 - 2019
24
2000 - 2009
1
1999 - 1999